Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2012
03/22/2012WO2012036208A1 Fat oxidation or energy metabolism enhancer
03/22/2012WO2012036193A1 Therapeutic agent for fatty liver disease containing p2x7 receptor inhibitory substance as active ingredient
03/22/2012WO2012034534A1 Use of the traditional chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue
03/22/2012WO2012034498A1 Product of functional health food that enhances organ immunity
03/22/2012WO2012034360A1 Insulin crystal microsphere, suspension and preparation method thereof
03/22/2012WO2011115447A9 C-terminal truncated peroxiredoxin-ii, and composition for preventing and treating apoptosis containing same
03/22/2012US20120071817 Stabilized glucagon solutions and uses therefor
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071560 Monoamine reuptake inhibitors
03/22/2012US20120071558 Compositions of very long chain polyunsaturated fatty acids and methods of use
03/22/2012US20120071557 Animal feed compositions of abscisic acid
03/22/2012US20120071556 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012US20120071555 Compositions of abscisic acid for animal health
03/22/2012US20120071550 Synergistic combinations of cartonoids and polyphenols
03/22/2012US20120071548 Therapeutic compositions
03/22/2012US20120071538 Pharmaceutical formulatons
03/22/2012US20120071535 Estrogen receptor modulators and uses thereof
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071528 Methods and compositions for treatment of diabetes and dyslipidemia
03/22/2012US20120071526 Compounds for the treatment of metabolic disorders
03/22/2012US20120071516 Compounds that modulate intracellular calcium
03/22/2012US20120071514 Benzoxazolone derivatives as aldosterone synthase inhibitors
03/22/2012US20120071512 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/22/2012US20120071506 Methods for treating cns disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071502 Novel phenoxyisobutyric acid compounds and methods for synthesis
03/22/2012US20120071494 Pyrazolopyridine kinase inhibitors
03/22/2012US20120071489 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
03/22/2012US20120071473 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
03/22/2012US20120071471 Novel benzoxazinone derivatives useful for the treatment of cns disorders
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071469 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120071461 Substituted Benzamide Compounds
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/22/2012US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/22/2012US20120071458 Methods for treating obesity
03/22/2012US20120071451 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid
03/22/2012US20120071440 Pharmaceutical Composition For Enhancing Adiponectin Production And Food Useful Therefor
03/22/2012US20120071427 Novel antidiabetic furostanolic saponin rich (fsr) fraction from fenugreek seeds
03/22/2012US20120071408 Formulations for achieving weight loss
03/22/2012US20120071403 Methods for Treating Type 2 Diabetes in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs Employing an SGLT2 Inhibitor and Compositions Thereof
03/22/2012US20120071402 Protease Stabilized, Pegylated Insulin Analogues
03/22/2012US20120071401 Amylin agonist compounds for estrogen-deficient mammals
03/22/2012US20120071400 Lipid metabolism-improving reagent
03/22/2012US20120071399 Sulfation of wnt pathway proteins
03/22/2012US20120071396 Compositions and Methods for Inhibiting the Interaction Between CFTR and CAL
03/22/2012US20120070520 Composition containing a bean extract for improving blood circulation and increasing vascular health
03/22/2012US20120070515 Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder
03/22/2012US20120070514 Aromatase inhibitor
03/22/2012US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives
03/22/2012US20120070497 Use of boswellic acids for the prophylaxis and/or treatment of damage to and/or inflammation of the islets of langerhans
03/22/2012US20120070487 Alkylsaccharide compositions with nutraceuticals
03/22/2012US20120070485 method for producing a device applicable to biological tissues, particularly a patch for treating damaged tissues, and a device obtained by said method
03/22/2012US20120070449 Methods of treating inflammation
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070425 TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC Beta-CELL DYSFUNCTION AND FOR Beta-CELL PROLIFERATION
03/22/2012US20120070410 Imidazolothiazole compounds and methods of use thereof
03/22/2012US20120070386 Trehalulose-containing composition, its preparation and use
03/22/2012US20120070380 Ingestible salt grabber
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012CA2811525A1 Piperidinyl-substituted lactams as gpr119 modulators
03/22/2012CA2810243A1 Formulations of guanylate cyclase c agonists and methods of use
03/22/2012CA2809641A1 Pharmaceutical and nutraceutical compositions of abscisic acid
03/21/2012EP2431463A1 Test agent for visceral obesity and use thereof
03/21/2012EP2431367A2 Fused cyclic compounds as GPR40 receptor modulators
03/21/2012EP2431362A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/21/2012EP2431044A1 Probiotics to influence fat metabolism and obesity
03/21/2012EP2431043A1 Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
03/21/2012EP2431041A1 Pharmaceutical composition for treating cardiovascular disorder and use thereof
03/21/2012EP2431037A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
03/21/2012EP2430455A2 Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/21/2012EP2430194A2 Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/21/2012EP2430025A1 Sitagliptin synthesis
03/21/2012EP2430023A1 Azacyclic spiroderivatives as hsl inhibitors
03/21/2012EP2429657A2 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes
03/21/2012EP2429561A1 Decolorized extracts of the plant pandanus conoideus
03/21/2012EP2429523A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
03/21/2012EP2429516A2 Combination of a pbospboinositkle 3-ks ase inhibitor and an antidiabetic compound
03/21/2012EP2429513A2 Methods for treatment of disease using an epimetabolic shifter (coenzyme q10)
03/21/2012EP2429512A2 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/21/2012EP2429511A2 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/21/2012EP2325169A9 Lisofylline analogues and their pharmeacuetical uses
03/21/2012EP2207775B1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP2123636B1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
03/21/2012EP2004593B1 Improved crystalline material
03/21/2012EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/21/2012EP1921917B1 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/21/2012EP1534248B1 Lasofoxifene tablet and its coating
03/21/2012EP1506409B1 Assays for modulators of asparaginyl hydroxylase
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012EP1248779B1 Glycosidase ihhibitors and preparation thereof
03/21/2012EP1158872B1 Dietary compositions and methods
03/21/2012CN1738630B Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102388054A Thiazolopyridine sirtuin modulating compounds
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 1298